Savsu Technologies
Date | Investors | Amount | Round |
---|---|---|---|
$1.0m | Seed | ||
$5.0m | Early VC | ||
N/A | Acquisition | ||
Total Funding | CAD8.2m |
Recent News about Savsu Technologies
EditSavsu Technologies specializes in providing advanced solutions for the transportation and management of live cell therapies. Operating in the biotechnology, cell therapy, gene therapy, regenerative medicine, and precision medicine markets, Savsu serves clients ranging from clinical trial organizations to commercial entities. The company's core product, the evo system, offers a fully integrated solution designed to ensure the thermal stability and integrity of live cells during transit. This system includes a cloud-based software platform that provides real-time data visibility, helping to prevent costly thermal excursions and lost shipments that could jeopardize multi-million dollar investments. Savsu's business model revolves around selling and supporting its evo system, which includes both hardware and software components. Revenue is generated through the sale of these systems, as well as through ongoing service and support contracts. The company stands out for its ability to scale solutions from clinical trials to full commercialization, providing a single vendor solution for all live cell temperature management needs.
Keywords: live cell transport, thermal stability, biotechnology, cell therapy, gene therapy, regenerative medicine, precision medicine, clinical trials, cloud-based software, data management.